Dental Bone Graft Substitutes Market Report Suite for the US | 2017-2023 | MedSuite | Dental Bone Graft Substitutes, Dental Growth Factor, Dental Barrier Membranes

Dental Bone Graft Substitutes Market Report Suite for the US | 2017-2023 | MedSuite | Dental Bone Graft Substitutes, Dental Growth Factor, Dental Barrier Membranes


  • Year: 2017
  • Scope: 2013-2023
  • Region: United States
  • Published Date: 5/1/2017
  • Pages: 186
  • Type: MedSuite

The full report suite on the U.S. market for dental bone graft substitutes (DBGS) and other biomaterials includes dental bone graft substitutes, dental growth factors and dental barrier membranes.

Major Segments Covered in the Dental Bone Graft Substitutes Market Report Suite

Overall, the U.S. market for dental bone graft substitutes and other biomaterials was valued at $368 million in 2016. This is expected to increase over the forecast period at a CAGR of 5.3% to reach $530.1 million by 2023.

The full report suite on the U.S. market for dental bone graft substitutes (DBGS) and other biomaterials includes dental bone graft substitutes, dental growth factors and dental barrier membranes.

While this report suite contains all US Dental Bone Graft Substitutes data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the Dental Bone Graft Substitutes market research that you need. You can view all these included reports and segmentation here:

  • US Market Overview for Dental Bone Graft Substitutes and Other Biomaterials 2017 – MedView: Gives an easily accessible view of all dental bone graft substitutes markets and trends, and aggregates the data together for a picture of the total US market.
  • US Procedure Numbers for Dental Bone Graft Substitutes and Other Biomaterials 2017 – MedPro: Using a number of databases, internal and external, we’re able to provide you with the total volume of dental bone graft substitute procedures being performed for each of the markets mentioned in this suite of reports.
  • US Product Portfolio for Dental Bone Graft Substitutes and Other Biomaterials 2017 – MedFolio: Covering all segmentation within this dental bone graft substitute suite we include insight on all available products in each market, any recalls and clinical trials.
  • US Market Report for Dental Bone Graft Substitutes 2017 – MedCoreThe bone grafting market is segmented on the basis of the material’s origins. Dental bone graft procedures include autografts, allografts, xenografts and synthetics.
  • US Market Report for Dental Growth Factor 2017 – MedCore: Dental growth factor and tissue engineering products is a broad category that encompasses products used for facilitating and enhancing bone regeneration. This includes growth factors and enamel matrix protein solutions. Platelet rich plasma (PRP) is also used for these purposes, but will not be considered within this report.
  • US Market Report for Dental Barrier Membranes 2017 – MedCore: Barrier membranes are a critical component to regeneration therapy and are aimed at restoring the form and function of the mouth. Commercially available on the market, barrier membranes function in dental surgeries to help retain bone grafting materials, to exclude epithelium and connective tissue from entering into sites of desired bone and ligament regeneration, or for the combination of these reasons. Whether restoring lost bone around teeth or implants, or in larger areas of the jaws affected by trauma or disease, too often there is inadequate gingival tissue to cover the membranes, leading to membrane exposure, extensive membrane contamination and procedural failure, which is unacceptable.
  • OTHER INFORMATION – Company Profiles and SWOT, Disease Overviews, & Related Press Releases from Top Competitors

Buying all of these reports together in this suite package will provide you with substantial discounts from the separate prices. Request Pricing to Learn More

Dental Bone Graft Substitute Market Trends

In 2016, the dental bone graft substitute, dental growth factor and dental barrier membrane markets exhibited similar levels of growth. The dental barrier membrane market stood out somewhat with a 5.8% CAGR, representing the fastest growing segment within the dental biomaterials market. The expanding procedural volume is occurring in parallel to growth of dental implant procedures. The demand for dental implants is growing with the aging population, since elderly people tend to have more missing teeth than younger generations. Implantology has also become incorporated into the educational curriculum of GPs, further facilitating growth of procedures.

Dental Bone Graft Substitute Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2023, and Historical Data to 2013
  • Market Drivers & Limiters for Each Dental Bone Graft Substitute Device Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Dental Bone Graft Substitute Procedure Volumes
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors
  • Related Press Releases from Top Competitors

Bone Graft Substitutes Companies Analyzed

The dental bone graft substitute and barrier membrane markets in the U.S. are largely controlled by four main competitors: Geistlich, Zimmer Biomet, BioHorizons and ACE Surgical. These companies collectively held about 59% of the combined market for dental bone graft substitutes and other biomaterials in 2016. However, the dental growth factor market was unique in its competitive landscape as there are currently only four dental growth factors available in the U.S. market. As such, the respective space is dominated by companies such as BioHorizons, Straumann and Osteohealth.

History of Our Dental Bone Graft Substitutes Market Research

We’ve been doing market research for medical devices for over a decade. We specialize in it, and the dental bone graft substitute market was one of our original reports that helped build trust in our research and methodology. We have built relationships with the top competitors in the dental bone graft substitutes market so that we can gather proprietary information in confidence to assure more accurate research – that our partners and clients then benefit from.

Because we’re a third party researcher, we have the ability to reach well into the top dental device companies and look at a multi-angle approach to our research. Not only do we consider financial filings, we conduct interviews, use hospital and procedural databases, and our own history of research to create a picture of the market that’s incredibly accurate.

Our clients have used our dental bone graft substitutes market research for years to strategize new markets to break into, submit SEC filings, decide sales and marketing strategies, plan acquisitions and product launches, and provide a 3rd party source to show investors, boards, and senior executives.

The "US Market Report Suite for Dental Bone Graft Substitutes 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Zimmer Biomet
ACE Surgical
Tissue Banks
LifeNet Health
Dentsply Sirona
Keystone Dental
Others include: AB Dental, Benco, Bicon, BTI, Collagen Matrix, Cortex Dental, Curasan, Datum Dental, Dentium USA, Dyna Dental, Henry Schein, Impladent LTD, Implant Direct, Inion, KaVo Kerr, Keystone Dental, LifeNet Health, MegaGen, MIS Implants, Nobel Biocare, NovaBone, Osteogenics, Osteohealth, Patterson, Regenetix, Snoasis Medical, Straumann, Unicare Biomedical, etc.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Thank you!

Report Type Info

Single License: A single license is for use by a single individual only. Usage rights may not be transferred, sold or distributed by any means.

Site License: A site license allows sharing of the reports between various users within the purchasing company’s designated business address within this agreement.

Corporate License: A corporate license is for the use of one corporation. A corporation is defined as any business entity incorporated under a single name. Separate corporations operating under the same parent company are not included in this license.

Executive Summary: An in-depth summary of the reports associated with the related MedSuite product.



Sign Up

Already have an account? Sign in